SPDYE10
gene geneOn this page
Summary
SPDYE10 (speedy/RINGO cell cycle regulator family member E10, HGNC:51506) is a protein-coding gene on chromosome 7q11.23, encoding Speedy protein E10 (P0DUX0).
Enables acetylcholine receptor regulator activity.
Source: NCBI Gene 643862 — RefSeq curated summary.
At a glance
- MANE Select transcript:
NM_001382505
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:51506 |
| Approved symbol | SPDYE10 |
| Name | speedy/RINGO cell cycle regulator family member E10 |
| Location | 7q11.23 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000274570 |
| Ensembl biotype | protein_coding |
| Entrez | 643862 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 2 protein_coding_CDS_not_defined, 2 protein_coding
ENST00000576332, ENST00000612005, ENST00000682856, ENST00000691996
RefSeq mRNA: 2 — MANE Select: NM_001382505
NM_001382504, NM_001382505
CCDS: CCDS94117
Canonical transcript exons
ENST00000691996 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002466988 | 73106340 | 73106444 |
| ENSE00003756816 | 73106567 | 73106810 |
| ENSE00003920331 | 73112123 | 73112705 |
| ENSE00003924731 | 73110922 | 73111140 |
| ENSE00003926086 | 73108517 | 73108602 |
| ENSE00003928243 | 73109830 | 73109888 |
| ENSE00003928607 | 73115357 | 73115542 |
| ENSE00003930198 | 73155323 | 73155431 |
| ENSE00003930867 | 73104008 | 73105486 |
Expression profiles
Bgee: expression breadth ubiquitous, 131 present calls, max score 85.86.
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sural nerve | UBERON:0015488 | 85.86 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 79.13 | gold quality |
| left testis | UBERON:0004533 | 78.66 | gold quality |
| testis | UBERON:0000473 | 78.16 | gold quality |
| right testis | UBERON:0004534 | 77.48 | gold quality |
| colonic epithelium | UBERON:0000397 | 76.33 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 67.63 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 65.87 | gold quality |
| adrenal tissue | UBERON:0018303 | 64.16 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 63.54 | gold quality |
| liver | UBERON:0002107 | 61.58 | gold quality |
| tonsil | UBERON:0002372 | 61.54 | gold quality |
| right lobe of liver | UBERON:0001114 | 61.41 | gold quality |
| corpus callosum | UBERON:0002336 | 59.77 | gold quality |
| cerebellum | UBERON:0002037 | 59.62 | gold quality |
| cerebellar cortex | UBERON:0002129 | 59.44 | gold quality |
| primary visual cortex | UBERON:0002436 | 59.37 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 59.32 | gold quality |
| blood | UBERON:0000178 | 59.17 | gold quality |
| esophagus mucosa | UBERON:0002469 | 58.94 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 58.80 | gold quality |
| endometrium | UBERON:0001295 | 58.66 | gold quality |
| placenta | UBERON:0001987 | 58.56 | gold quality |
| calcaneal tendon | UBERON:0003701 | 58.42 | gold quality |
| metanephros cortex | UBERON:0010533 | 58.28 | gold quality |
| adenohypophysis | UBERON:0002196 | 58.10 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 57.94 | gold quality |
| left ovary | UBERON:0002119 | 57.93 | gold quality |
| spleen | UBERON:0002106 | 57.83 | gold quality |
| apex of heart | UBERON:0002098 | 57.74 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.42 |
Regulation
Is transcription factor: no
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Spdye4b | ENSMUSG00000029586 |
| mus_musculus | Spdye4a | ENSMUSG00000039296 |
| rattus_norvegicus | Spdye4 | ENSRNOG00000058563 |
Paralogs (18): SPDYE1 (ENSG00000136206), SPDYE5 (ENSG00000170092), SPDYE2B (ENSG00000173678), SPDYE4 (ENSG00000183318), SPDYE12 (ENSG00000184616), SPDYE16 (ENSG00000185040), SPDYE17 (ENSG00000186645), SPDYE2 (ENSG00000205238), SPDYE18 (ENSG00000205482), SPDYE3 (ENSG00000214300), SPDYE21 (ENSG00000230358), SPDYE6 (ENSG00000260097), SPDYE9 (ENSG00000262461), SPDYE8 (ENSG00000273520), SPDYE11 (ENSG00000275976), SPDYE15 (ENSG00000286014), SPDYE13 (ENSG00000286038), SPDYE14 (ENSG00000286137)
Protein
Protein identifiers
Speedy protein E10 — P0DUX0 (reviewed: P0DUX0)
All UniProt accessions (1): P0DUX0
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the Speedy/Ringo family.
RefSeq proteins (2): NP_001369433, NP_001369434* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR020984 | Speedy | Family |
| IPR057742 | Speedy_E | Family |
Pfam: PF11357
UniProt features (3 total): chain 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P0DUX0-F1 | 71.23 | 0.43 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 3 (showing top):
chr7q11, GOMF_KINASE_BINDING, JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP
GO Biological Process (1): positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737)
GO Molecular Function (1): protein kinase binding (GO:0019901)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of cyclin-dependent protein serine/threonine kinase activity | 1 |
| cyclin-dependent protein serine/threonine kinase activity | 1 |
| positive regulation of cell cycle | 1 |
| positive regulation of protein serine/threonine kinase activity | 1 |
| positive regulation of cyclin-dependent protein kinase activity | 1 |
| kinase binding | 1 |
Protein interactions and networks
STRING
0 interactions, top by confidence (×1000):
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A0J9YY54, A0A494C086, A0A494C0Z2, A0A494C191, A6NHP3, A6NIY4, A6NJR5, A6NNV3, B4DH59, F6SZT2, P0C6Y7, P0CI01, P0DKJ7, P0DKJ8, P0DTA3, P0DUD1, P0DUD2, P0DUD3, P0DUD4, P0DUX0, P0DUX1, P0DV79, P79386, Q08AG5, Q13342, Q16666, Q3BBV2, Q495Y8, Q587J8, Q5JRC9, Q5QGU6, Q5RD14, Q5RKG3, Q63HK3, Q6ITT4, Q7TQI8, Q86T75, Q8IWY8, Q8N660, Q8NFV5
Diamond homologs: A0A494C086, A0A494C0Z2, A0A494C191, A6NHP3, A6NIY4, A6NJR5, A6NKU9, A6NLX3, A6NNV3, P0CI01, P0DTA3, P0DUD1, P0DUD2, P0DUD3, P0DUD4, P0DUX0, P0DUX1, P0DV79, Q495Y7, Q495Y8, Q5IBH6, Q5IBH7, Q5MJ68, Q5MJ70, Q8NFV5, Q8R496, Q9PU13, Q9YGL1
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1018987 (7:73122961 A>G), RS10248431 (7:73146520 C>T), RS111517749 (7:73113747 T>A,C), RS111714962 (7:73150971 C>A), RS112105869 (7:73119402 A>G), RS112154436 (7:73150970 C>A), RS112388653 (7:73115273 T>C), RS112438073 (7:73156142 T>A,C), RS112511866 (7:73117244 A>G), RS1156246504 (7:73128995 A>G,T), RS1156248678 (7:73142213 G>A), RS1156285684 (7:73114606 G>A), RS1156291901 (7:73156041 T>C), RS1156374586 (7:73114150 C>A,T), RS1156393958 (7:73156636 G>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
1 total (human), top 1 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Okadaic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.